BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 26414119)

  • 1. A combination of retinal morphology and visual electrophysiology testing increases diagnostic yield in Parkinson's disease.
    Miri S; Glazman S; Mylin L; Bodis-Wollner I
    Parkinsonism Relat Disord; 2016 Jan; 22 Suppl 1():S134-7. PubMed ID: 26414119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of inner retinal thickness evaluated by spectral-domain optical coherence tomography and contrast sensitivity in Parkinson disease.
    Adam CR; Shrier E; Ding Y; Glazman S; Bodis-Wollner I
    J Neuroophthalmol; 2013 Jun; 33(2):137-42. PubMed ID: 23612240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation Between Structural and Functional Retinal Changes in Parkinson Disease.
    Kaur M; Saxena R; Singh D; Behari M; Sharma P; Menon V
    J Neuroophthalmol; 2015 Sep; 35(3):254-8. PubMed ID: 25807477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrophysiology and optical coherence tomography to evaluate Parkinson disease severity.
    Garcia-Martin E; Rodriguez-Mena D; Satue M; Almarcegui C; Dolz I; Alarcia R; Seral M; Polo V; Larrosa JM; Pablo LE
    Invest Ophthalmol Vis Sci; 2014 Feb; 55(2):696-705. PubMed ID: 24425856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between retinal morphological and functional findings and clinical severity in Parkinson's disease.
    Altintaş O; Işeri P; Ozkan B; Cağlar Y
    Doc Ophthalmol; 2008 Mar; 116(2):137-46. PubMed ID: 17962989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Scanning laser polarimetry and spectral domain optical coherence tomography for the detection of retinal changes in Parkinson's disease.
    Stemplewitz B; Keserü M; Bittersohl D; Buhmann C; Skevas C; Richard G; Hassenstein A
    Acta Ophthalmol; 2015 Dec; 93(8):e672-7. PubMed ID: 26066643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromatic and achromatic visual evoked potentials in Parkinson's disease.
    Büttner T; Kuhn W; Müller T; Heinze T; Pühl C; Przuntek H
    Electroencephalogr Clin Neurophysiol; 1996 Sep; 100(5):443-7. PubMed ID: 8893662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Applications of visual evoked potentials and Fourier-domain optical coherence tomography in Parkinson's disease: a controlled study.
    Quagliato LB; Domingues C; Quagliato EM; Abreu EB; Kara-Junior N
    Arq Bras Oftalmol; 2014 Aug; 77(4):238-42. PubMed ID: 25410176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel retinal biomarker for Parkinson's disease: Quantifying the foveal pit with optical coherence tomography.
    Slotnick S; Ding Y; Glazman S; Durbin M; Miri S; Selesnick I; Sherman J; Bodis-Wollner I
    Mov Disord; 2015 Oct; 30(12):1692-5. PubMed ID: 26340519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of retinal changes in idiopathic Parkinson's disease using high-resolution optical coherence tomography and heidelberg retina tomography.
    Bittersohl D; Stemplewitz B; Keserü M; Buhmann C; Richard G; Hassenstein A
    Acta Ophthalmol; 2015 Nov; 93(7):e578-84. PubMed ID: 26267660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Foveal vision is impaired in Parkinson's disease.
    Bodis-Wollner I
    Parkinsonism Relat Disord; 2013 Jan; 19(1):1-14. PubMed ID: 22998939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optical coherence tomography retinal thickness and volume measurements in X-linked retinoschisis.
    Andreoli MT; Lim JI
    Am J Ophthalmol; 2014 Sep; 158(3):567-73.e2. PubMed ID: 24879947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Independent patterns of damage within magno-, parvo- and koniocellular pathways in Parkinson's disease.
    Silva MF; Faria P; Regateiro FS; Forjaz V; Januário C; Freire A; Castelo-Branco M
    Brain; 2005 Oct; 128(Pt 10):2260-71. PubMed ID: 16000338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The predictive value of optical coherence tomography after grid laser photocoagulation for diffuse diabetic macular oedema.
    Soliman W; Sander B; Soliman KA; Yehya S; Rahamn MS; Larsen M
    Acta Ophthalmol; 2008 May; 86(3):284-91. PubMed ID: 18005220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a prediction formula of Parkinson disease severity by optical coherence tomography.
    Jiménez B; Ascaso FJ; Cristóbal JA; López del Val J
    Mov Disord; 2014 Jan; 29(1):68-74. PubMed ID: 24458320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contrast sensitivity and foveal microstructure following vitrectomy for epiretinal membrane.
    Sugiura Y; Okamoto F; Okamoto Y; Hiraoka T; Oshika T
    Invest Ophthalmol Vis Sci; 2014 Nov; 55(11):7594-600. PubMed ID: 25370511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Correlation of retinal sensitivity, visual acuity and central macular thickness in different types of diabetic macular edema].
    Yang XL; Zou HD; Xu X
    Zhonghua Yan Ke Za Zhi; 2013 Dec; 49(12):1081-8. PubMed ID: 24499694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optical coherence tomography as a tool to evaluate retinal changes in Parkinson's disease.
    Mailankody P; Battu R; Khanna A; Lenka A; Yadav R; Pal PK
    Parkinsonism Relat Disord; 2015 Oct; 21(10):1164-9. PubMed ID: 26297381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the visual system with visual evoked potential and optical coherence tomography in patients with idiopathic Parkinson's disease and with multiple system atrophy.
    Batum M; Ak AK; Arı MS; Mayali H; Kurt E; Selçuki D
    Doc Ophthalmol; 2022 Oct; 145(2):99-112. PubMed ID: 35881261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Papillomacular bundle and inner retinal thicknesses correlate with visual acuity in nonarteritic anterior ischemic optic neuropathy.
    Rebolleda G; Sánchez-Sánchez C; González-López JJ; Contreras I; Muñoz-Negrete FJ
    Invest Ophthalmol Vis Sci; 2015 Jan; 56(2):682-92. PubMed ID: 25587057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.